Aequim Alternative Investments LP

Holdings History for BRIDGEBIO PHARMA INC - NOTE 2.500% 3/1

Investment type: Debt / NOTE 2.500% 3/1

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Principal	Change	Activity %	Price	All Holders
31 Dec 2021		-0.79%	$0	0	-14,800,000	-100%	188.78%	Q4 2021
30 Sep 2021	0.79%	-1%	$20,457,000	14,800,000	-19,200,000	-56%	138.22%	Q3 2021
30 Jun 2021	2.4%	+0.85%	$55,930,000	34,000,000	+12,000,000	+55%	164.5%	Q2 2021
31 Mar 2021	2.3%	+2.3%	$36,397,000	22,000,000	+22,000,000	NEW	165.44%	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.